Glenmark Pharmaceuticals (GLENMARK.NSE) null Earnings

30JunConfirmed
Sep 17
Dec 17
Mar 18
Jun 18
3.31
5.09
6.87
8.65

Details

Expected EPS
6.36
Actual EPS
8.26
Surprise EPS
1.9
Surprise Percent
+29.87%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 8.26 per share for .

0 Comments

Share your thoughts